Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1504
https://www.valueinhealthjournal.com/article/S1098-3015(15)03580-9/fulltext
Title :
Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03580-9&doi=10.1016/j.jval.2015.09.1504
First page :
A588
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1407